Guidant CRT-D Non-Ischemic Label Expansion Endorsed By FDA Panel

Guidant cardiac resynchronization therapy defibrillators reduce heart failure mortality and symptoms for both ischemic and non-ischemic patients but may not prevent hospitalizations, according to FDA's Circulatory System Devices Panel